EXACT SCIENCES CORP (EXAS) Stock Analyst Ratings
NASDAQ:EXAS • US30063P1057
103.36 USD
+0.05 (+0.05%)
At close: Feb 18, 2026
103.36 USD
0 (0%)
After Hours: 2/18/2026, 8:00:02 PM
ChartMill assigns a Buy % Consensus number of 67% to EXAS. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 103.87. This target is 0.49% above the current price.
- EXAS was analyzed by 29 analysts. The buy percentage consensus is at 67. So analysts seem to be have mildly positive about EXAS.
- In the previous month the buy percentage consensus was at a similar level.
- EXAS was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-20 | Mizuho | Downgrade | Outperform -> Neutral |
| 2026-01-05 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-11-25 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-11-24 | Benchmark | Downgrade | Buy -> Hold |
| 2025-11-24 | Jefferies | Downgrade | Buy -> Hold |
| 2025-11-21 | Guggenheim | Downgrade | Buy -> Neutral |
| 2025-11-21 | William Blair | Downgrade | Outperform -> Market Perform |
| 2025-11-21 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2025-11-21 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-11-20 | BTIG | Downgrade | Buy -> Neutral |
| 2025-11-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-04 | TD Cowen | Maintains | Buy -> Buy |
| 2025-11-04 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-04 | BTIG | Maintains | Buy -> Buy |
| 2025-11-04 | Benchmark | Maintains | Buy -> Buy |
| 2025-11-04 | Stifel | Maintains | Buy -> Buy |
| 2025-11-04 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-04 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-22 | BTIG | Maintains | Buy -> Buy |
| 2025-10-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-07 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-10-02 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-11 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-08-12 | BTIG | Maintains | Buy -> Buy |
| 2025-08-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-07 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-08-07 | Barclays | Maintains | Overweight -> Overweight |
EXACT SCIENCES CORP / EXAS FAQ
What is the price target for EXAS stock?
29 analysts have analysed EXAS and the average price target is 103.87 USD. This implies a price increase of 0.49% is expected in the next year compared to the current price of 103.36.
What is the consensus rating for EXACT SCIENCES CORP (EXAS) stock?
The consensus rating for EXACT SCIENCES CORP (EXAS) is 66.8966 / 100 . This indicates that analysts generally have a neutral outlook on the stock.